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Background: While the development and evaluation of clinical ethics services in Norway has been recognized
internationally, the country’s research ethics infrastructure at times may have been less well developed. In 2016,
media interest in the controversial nature of some health services research and pilot studies highlighted gaps in the
system with certain types of research having no clear mechanisms through which they may be given due
independent consideration. It is not clear that new legislation, implemented in 2017, will address this problem.
Summary: We explore relevant law, committee scope, and the function of the system. We show that 1) Norwegian
law provides for ethics assessment for all forms of health research; 2) regional RECs in Norway might not have
always enforced this provision, considering some interventional health services research to be outside their remit;
and 3) Norwegian law does not explicity provide for local/university RECs, meaning that, in practice, there may be
no readily accessible mechanisms for the assessment of research that is excluded by regional RECs. This may
include health services research, pilot studies, and undergraduate research. New 2017 legislation has no effect on
this specifically but focuses on institutions regulating researcher activity. This may place researchers in the difficult
situation of on one hand, needing to hold to recognized ethical standards, while on the other, not readily having
access to independent committee scrutiny to facilitate consistent operation with these standards.
Conclusion: To support researchers in Norway and to protect the public, it may be necessary either to widen the
regional RECs’ remit or to make legislative alterations that permit and do not discourage the existence of local RECs.
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In 1963, three doctors at the Jewish Chronic Disease
Hospital, in Brooklyn, New York, injected cancer cells into
22 patients without their knowledge or consent [1]. The
study was conducted without institutional review, but with
the funding of the US Public Health Service, and the
American Cancer Society [2]. Following litigation by sev-
eral doctors, the New York Board of Regents decided that
the study violated medical ethics [1]. In 1964, during a
period of heightened debate, the UK Royal College of
Physicians published a statement recommending that all
human research be subject to ethics review, and the
World Medical Association adopted the Declaration of
Helsinki (the Declaration) [3, 4].* Correspondence: rob.froud@kristiania.no
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the use of independent committees, which proceeded to
proliferate across the US and Europe [5]. In Norway, a
Norwegian Council of Medical Research working group
proposed a system comprising four RECs, each respon-
sible to an overseeing appeal body and devolving assess-
ments to local RECs (LRECs).1 However, the Ministry of
Social Affairs considered the proposal too intricate [6].
In 1978, the Research Council of Norway and the Council
of Medical Research established a committee with a
mandate to cover all research pertaining to human health,
as required by the Declaration. In addition, the largest
hospitals established their own LRECs.
Since the 1980s, the field of bioethics, and medical eth-
ics in particular, has flourished in Norway, producing
some of the leading figures in international bioethics re-
search in areas such as resource allocation and clinical
ethics support [7, 8]. Clinical ethics committees are man-
dated in Norwegian hospitals and there is an extensivele is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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munity health care settings. However, the main focus for
development of a research ethics infrastructure has been
through legislation and regulation.
In the early 1980s, a lack of clarity regarding funding
and organization, threatened the Norwegian research eth-
ics system, which was criticized as lagging behind other
Nordic countries [9]. In 1985, the Ministry of Culture and
Education established Medical and Health Research RECs
and, in 2006, following adoption of the Research Ethics
Act, these were provided with ring-fenced funding [10].
The aim of the 2006 Research Ethics Act (which came
into force in 2007) was to ensure that research carried out
by public and private institutions is conducted in accord-
ance with recognized ethical standards. This legislation,
which would later be repealed by the 2017 Act (below),
provided for national and regional ethics committees and
established their jurisdiction over research projects being
conducted in Norway on human subjects, and provided a
mechanism for appeals to the national committee in the
case of rejected applications, and a commission for the
investigation of scientific misconduct.
In 2008, the Health Research Act was passed and came
into force in 2009 [11]. The aim of the 2008 Act is to
promote good ethically sound medical and health re-
search (Clause §1) and applies to all medical and health
research on human beings, human biological material or
personal health data, including pilot studies and experi-
mental treatments (§2) [11]. It has been the role of
Norway’s regional RECs to enforce this Act. The 2008
Act outlines a legal requirement for a protocol describ-
ing research within its scope (§6). Clause §9 and §10
provides that an application for prior approval must be
submitted together with the protocol to the regional
committee for medical and health research ethics. In §4,
‘medical and health research’ is defined as ‘activity con-
ducted using scientific methods to generate new know-
ledge about health and disease’. Thus, since the 2008
Act came into force in 2009, the law has been explicit
that all Norwegian medical and health research (i.e. re-
search that generates new knowledge about health and
disease) on human beings, using human biological ma-
terial, or personal health data, must have prior approval
from one of the seven regional medical and health RECs
in Norway.
The system, as it was instituted in 2009, continued
unchanged and until new legislation in 2017, which
followed several research ethics related scandals that
cast the light of the media interest and public atten-
tion throughout 2016 onto specific research studies.
During these debates certain weaknesses of the system
were alluded to by stakeholders, which included the
person who led the committee involved in the drafting
of the 2006 Act.The 2017 Research Ethics Act repealed the 2006 Act
[12]. The Minstry of Education, Science, and Culture
explained that its motivation in proposing the new law
was to strengthen the ethical component in Norwegian
research through promulgation of the responsibility of
individual researchers and research institutions [13]. The
new legislation expands on material in the 2006 law,
adding researcher and institutional responsibilities and
conferring on Norwegian research institutions a duty to
follow ethical norms; provide researcher training; assem-
ble committees for managing misconduct, fraudulent
cases, and breaches of ethics; and to report any breaches
to a national examination committee, for which the new
law also provides.
Currently, some confusion may remain surrounding
procedures for the assessment of health and medical re-
search in Norway that is considered by the regional
committees to be out of their remit. It may not be clear
what mechanisms are permitted to be in place for ap-
propriate review of such research [14, 15]. There may be
extant gaps in the mechanisms provided by the legal and
regulatory infrastructure.
In this paper, we consider relevant law, its interpretation
and cases of practice, and possible gaps in the infrastruc-
ture and any implications. Our objectives are to: 1) exam-
ine the current Norwegian system; 2) stimulate debate on
research ethics infrastructure using Norway as an ex-
ample; and 3) consider desirable directions of travel that
may improve the situation in Norway for key stakeholders,
including ethics committees, researchers, and the public.
Analysis
One of the studies that received media scrutiny in 2016,
was a study defined as a pilot RCT. The study, which
explored Human Papilloma Virus (HPV) screening in fe-
male patients, and included 60,000 female participants,
was reported as being judged by the regional REC to be
exploring implementation rather than generating new
knowledge and considered exempt [16, 17]. The REC
chair at the time stated her view that the pilot RCT fell
outside the wording of the Act:
“[The principle is that the Health Research Act applies
to research on health and disease. So the question is
whether this is research that will provide new
knowledge about this, or whether it's knowledge of
implementing. (…) One can always discuss whether to
define a project like this as health services research or
quality control. Anyway, both these definitions fall
outside the Health Research Act. It is possible to argue
that definitions of health services research and quality
assurance should be included under one of the points
of law, but they are not.]”’- (Translated from
Norwegian by the authors) [17]
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drafted the 2006 Health Research Act, disagreed with
the interpretation, explaining that there was no doubt in
his view that the pilot RCT constituted research: [17]
“[I was in no doubt that the project that was presented
to the council, fell within the research definition…. When
I led the Health Research committee, our intention
was to embrace more projects like this. We experienced
that research was being done in the country disguised
as quality assurance or test (pilot) treatment. The
intention (of the Act) was that all exploration relating
to new knowledge should be defined as research – in
particular to ensure informed consent, which is an
important ethical requirement]” [17].
The interpretation of the limits of ‘medical and health
research on human beings’, and the accompanying caveat
in the §4 definition of the 2008 Act (above), that the re-
search must generate ‘new knowledge’, may be central to
this debate. We suggest that the purpose of research and
scientific inquiry is to explore research objectives and
provide answers to research questions. We also suggest
that it is axiomatic that the intent of health and medical
research is to generate new knowledge, and that the re-
verse also holds; i.e., that (systematic) exploration with
the intention of producing new knowledge, is research.
The HPV RCT does appear very large for a pilot
study. Given that it randomized 60,000 patients (n.b in
2018 this equates to about 5% of the Norwegian fe-
male population between the 34–69 age range of entry
into the study); some might consider this more appro-
priately classified a mega-trial [18, 19]. Around 30
participants per arm is generally thought adequate for
estimating standard deviation and meeting typical
pilot/feasibility study objectives [20].
In any case, it is clear from §2 of the 2008 Act (above)
that its scope does include pilot studies and so notwith-
standing debate about the HPV RCT’s classification as
pilot, it would not be disqualified from consideration on
the basis of it being a pilot study. The distinction made
by the REC in its interpretation in this case appears to
be that the pilot study was thought to be health services
research (HSR), or quality assurance, and these kinds of
research are in their judgement not covered by the Act.
The Association for Health Services Research defines
HSR as “the multidisciplinary field of scientific investiga-
tion that studies how social factors, financing systems,
organizational structures and processes, health technolo-
gies, and personal behaviors affect access to health care,
the quality and cost of health care, and ultimately our
health and well-being. Its research domains are individ-
uals, families, organizations, institutions, communities,
and populations” [21]. HSR encompasses epidemiologicaland qualitative research approaches, as well as phase
III/IV clinical trials and pilot/feasibility studies.
A similar Norwegian HSR study that was a pilot RCT
of a national screening program for bowel cancer, was
published in the British Journal of Cancer in 2016 [22].
This study received REC consideration and approval
[23]. Thus, there may have been variable interpretation
of the letter of Norwegian law, affecting what has been
done in practice.
Some researchers who seek regional REC approval,
and who have been informed that it is outside the remit
of the 2008 Act, have queried the situation. For example,
Mæland et al discuss their experience when applying for
ethics approval for their research on work and health,
but being informed that such projects are not covered
by the Act [15]. In the work and health field, return to
work is seen as a health outcome and in this sense trials
seeking to improve RTW rates are trials seeking to im-
prove health; i.e. and are thus to seeking to generate new
knowledge [24]. There are grounds for concern if there
is no mechanism for independent assessment of proto-
cols for studies such as these.
There was also media interest in 2016 in research stud-
ies following allegations of doping in athletes in Norway.
One report alleged researchers applied to the REC for ap-
proval for a study that proposed to provide athletes with
asthma medications (whether or not athletes had the con-
dition) [25]. However, in this case it was reported that the
research had been performed before the ethics application
had been considered, and that the REC considered the
study to be quality assurance. In the publicly available
REC correspondence, the committee describes the project
as containing ethically questionable aspects, but con-
cluded the project fell outside of their mandate after
considering: 1) whether the project’s purpose is to try to
improve the quality of a given treatment; 2) whether the
project is to try their own practices against established
standards; and 3) whether the project involves manipulat-
ing the project participants in a way that would not other-
wise be done as part of routine clinical practice and
quality assurance [26]. It may not be clear how these
criteria relate to the wording of the 2008 Act.
A separate study that involved healthy cross-country
athletes, swimmers, and students (including minors) was
considered outside of REC remit because the study ob-
jective was to compare two different methods of meas-
urement [27]. However, in this case it later emerged that
participants had also received asthma medication as part
of the study and that this part of the protocol had not
been disclosed to the REC [14].
Separately to all these cases of HSR that were under the
media spotlight in 2016, we suggest that it may also be un-
clear what mechanisms exist to cover the assessment of
undergraduate research. NOKUT, the department
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gaging students with research early at undergraduate level
[28]. The 2008 Act must be considered to govern in cases
where the research is medical and health research on hu-
man beings (some undergraduate research might genu-
inely be considered to provide new knowledge); includes
biological materials (less likely); or manages personal
health data (not at all unlikely). As per the legislation
wording quoted above, such protocols then legally require
regional REC attention. In practice, whether a protocol is
reviewed by a regional REC may depend on subjective
judgment about whether such work is thought to contrib-
ute new health knowledge, if it not judged to be outside of
the Act for some other reason. If an undergraduate project
is not considered the supervising educational institution is
then placed in a difficult position: there may be no alter-
native legal mechanism for the projects to have inde-
pendent committee scrutiny. The legislation – i.e. that
all medical and health on human beings, human bio-
logical material, or personal health data, must be sent
to one of the government-appointed regional medical
and health research RECs – may prevent the establish-
ment of LRECs, which might otherwise review under-
graduate protocols. An institution wishing to err on the
side of caution might conclude that it should not per-
mit its students to conduct any primary research other
than systematic reviews, where data are already in the
public domain and ethics approvals are not required.
For comparison, in the UK, undergraduate institutions
usually convene their own RECs to consider health research
protocols (including experimental protocols) that fall out-
side the remit of the national Research Ethics Service [29].
There is a suggestion that departments with this duty also
function in Norway albeit under designations such as ‘The
Department of Research Support’, or ‘Commission for
Research Ethics’ [6]. It is not clear whether all research
institutions or universities have such departments nor if
they are legally permitted to function as ethics committees.
If appropriate ethics infrastructure is not in place, ex-
perimental student undergraduate research may pose
risk to public health. There would be no mechanism
for students/supervisors to publish results in any rep-
utable journals, as editors of journals may not view
the aforementioned internal departments as qualifying
independent ethics committees.
Implications for health services researchers working in
Norway
Most internationally-ranked journals insist upon prior
ethics approval for any health research involving the col-
lection of human data in accordance with the Vancouver
Convention [30]. If researchers in Norway are unable to
gain the prior views of RECs on pilot/HSR protocols, in
the absence of any other legal mechanism for assessment,researchers may be unable to satisfy a journal that a study
protocol has received due independent consideration. One
concern may be that researchers are being incentivized to
treat this as an obstacle to overcome. There is some evi-
dence that this has been viewed and institutionally recog-
nized as a publication obstacle and needs somehow to be
managed. Here is one such example:
“When publishing the results of a quality control
study, which does not require REK [the REC] approval,
a researcher (author) can ask REK for a general
statement for manuscript submission (“exempt from
IRB (Institutional Review Board) evaluation”). This
can be a convenient solution when you want to
publish in a journal that requires all results to be
based on a prior ethical review by the IRB. This is a
requirement that all the reputable scientific journals
have adopted and is based on Article 35 of the
Helsinki Declaration” [31].
Of course, not all journals have such stringent publica-
tion policies. In a brief review of recent articles in some
Norwegian journals we found a report of an interventional
study with no reference to ethical issues or whether inde-
pendent ethics review had been obtained.
Suggestions for future directions of travel
The 2017 legislation brings some change that may be wel-
comed. It may help to raise researcher standards through
the provision for institutional committees to manage re-
searcher misconduct. Decisions about prior approval may
be appealed to the National Research Ethics Committee
for Medicine and Health Sciences. However, it is still not
clear what types of study regional RECs will, or should,
consider. Moreover, there is no clear mechanism for
alternative consideration in the cases where RECs
consider the submitted protocol to be outside of their
remit (rather than rejected).
Without improvements in these areas we are con-
cerned that the issues identified in this paper may be set
to continue. With new law focusing principally on man-
aging misconduct at an institutional level, we are also
concerned an association could emerge between cases
that are considered by regional RECs to be outside of
their remit, and subsequent misconduct cases brought at
an institutional level against individual researchers.
Apart from protecting the public, independent REC
scrutiny may prevent researchers from making question-
able judgments when moving to explore what may ap-
pear to be the next logical hypothesis, without first
giving due consideration to all ethical issues. In this
sense, independent committees provide a valuable ser-
vice to researchers as well as to the wider public as the
ultimate intended beneficiaries. It is important that
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clear for researchers in Norway.
It would of course be an insurmountable task for re-
gional committees to consider all undergraduate proto-
cols. Legislative changes that clearly permits, encourages
and provides for the existence of independent LRECs to
address studies regional RECs consider outside of their
remits, may avoid straining REC resources at the same
time as ensuring a clear and practical mechanism for in-
dependent assessment of research considered to be out-
side of the regional RECs’ scope.
Conclusion
We have argued that in HSR and some undergraduate
health research in Norway, the a priori intent is to pro-
vide new knowledge of health and disease. Legally, re-
gional Norwegian RECs must consider such study
protocols. The effect of regional RECs declining to con-
sider these may breed confusion, difficulty in managing
ethical issues, and could risk public harm. New legisla-
tion provides mechanisms for institutional management
of researcher misconduct but does not address variable
interpretations of the Health Research Act and the re-
gional RECs’ remit. To protect public health, we suggest
it should either be made clear that assessing protocols
for pilot studies and other HSR should be within the re-
gional REC remit; or changes in legislation are needed to
permit the existence of local RECs that can provide in-
dependent scrutiny in-line with international standards.
Endnote
1For this paper, we define LRECs as committees con-
vened by institutions, such as universities and hospitals,
that have a composition and independence that is con-
sistent with the Declaration, and that may or may not be
independent of a larger national ethics infrastructure
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